Skip to main content

MoneyWorks4Me

Biogen Pharmachem - Quaterly Results

12 Feb 2026 Evaluate
Revenue reduced marginally to stand at Rs. 0.00 millions during the quarter ended December 2025. The figure stood at Rs. 0.00 millions during the year-ago period.The Total Profit for the quarter ended December 2025 of Rs. 4.63 millions grew from Rs.-3.14 millions Operating profit Margin for the quarter ended December 2025 improved to 4.63% as compared to -3.14% of corresponding quarter ended December 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 0.00 0.00 0.00 15.43 -0.91 -1795.60 8.38 23.82 -64.82
Other Income 5.42 2.28 137.72 4.37 -4.22 -203.55 0.00 0.00 0.00
PBIDT 4.63 -3.14 -247.45 13.17 -14.69 -189.65 -2.93 19.31 -115.17
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 4.63 -3.14 -247.45 13.17 -14.69 -189.65 -2.93 19.31 -115.17
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT 4.63 -3.14 -247.45 13.17 -14.69 -189.65 -2.93 19.31 -115.17
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 4.63 -3.14 -247.45 13.17 -14.69 -189.65 -2.93 19.31 -115.17
Equity 902.60 652.60 38.31 902.60 652.60 38.31 652.60 652.60 0.00
PBIDTM(%) 0.00 0.00 0.00 85.35 1614.29 -94.71 -34.96 81.07 -143.13
Peers
Company Name CMP
Redington 349.60
Adani Enterprises 2682.00
Amrapali Industries 32.78
Maxgrow India 174.80
Rashi Peripheral 689.15
View more..